BHCBausch Health Companies Inc.
Earnings
When Bausch Health Companies Inc. reports, what it reported each quarter, and how the stock took the results.
69 quarters. Jun 30, 2009 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Feb 17, after the close
Wed, Feb 17, 2027in 92 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Feb 16 – 26
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $2.80B
- Revenue, change from a year earlier: Q3 2026 +9.7%, Q2 2026 +12.7%, Q1 2026 +11.7%, Q4 2025 +9.3%
- Net income
- -$112.00M
- Net income, change from a year earlier: Q3 2026 +143.6%, Q2 2026 +74.3%, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 +139.6%, Q2 2026 +70.0%, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- $2.94B
- +9.7%
- Net income
- $436.00M
- +143.6%
- EPS
- $1.15
- +139.6%
Read · nothing to show- Revenue
- $2.85B
- +12.7%
- Net income
- $258.00M
- +74.3%
- EPS
- $0.68
- +70.0%
- Revenue
- $2.52B
- +11.7%
- Net income
- -$1.42B
- N/M
- EPS
- -$3.82
- N/M
- Revenue
- $2.80B
- +9.3%
- Net income
- -$112.00M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Oct 28, 2026 · after-hours | Oct 29, 2026 | 29 d | 10-Q | $2.94B | +9.7% | $1.15 | +28.8% | |
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · after-hours | Jul 30, 2026 | 30 d | 10-Q | $2.85B | +12.7% | $0.68 | +28.7% | |
| Q1 2026 | Mar 31, 2026 | Apr 29, 2026 · after-hours | Apr 30, 2026 | 30 d | 10-Q | $2.52B | +11.7% | -$3.82 | +2.3% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 18, 2026 · after-hours | Feb 19, 2026 | 50 d | 10-K | $2.80B | +9.3% | — | 4.2% | |
| Q3 2025 | Sep 30, 2025 | Oct 29, 2025 · after-hours | Oct 30, 2025 | 30 d | 10-Q | $2.68B | +6.8% | $0.48 | +12.0% | |
| Q2 2025 | Jun 30, 2025 | Jul 30, 2025 · after-hours | Jul 31, 2025 | 31 d | 10-Q | $2.53B | +5.3% | $0.40 | 7.8% | |
| Q1 2025 | Mar 31, 2025 | Apr 30, 2025 · after-hours | May 1, 2025 | 31 d | 10-Q | $2.26B | +4.9% | -$0.16 | 0.0% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 19, 2025 · after-hours | Feb 20, 2025 | 51 d | 10-K | $2.56B | +6.3% | — | +10.3% | |
| Q3 2024 | Sep 30, 2024 | Oct 30, 2024 · after-hours | Oct 31, 2024 | 31 d | 10-Q | $2.51B | +12.2% | -$0.23 | +12.6% | |
| Q2 2024 | Jun 30, 2024 | Jul 31, 2024 · after-hours | Aug 1, 2024 | 32 d | 10-Q | $2.40B | +10.9% | $0.03 | +1.2% | |
| Q1 2024 | Mar 31, 2024 | May 1, 2024 · after-hours | May 2, 2024 | 32 d | 10-Q | $2.15B | +10.8% | -$0.17 | 7.6% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Feb 21, 2024 · after-hours | Feb 22, 2024 | 53 d | 10-K | $2.41B | +9.8% | — | +5.9% | |
| Q3 2023 | Sep 30, 2023 | Nov 1, 2023 · after-hours | Nov 2, 2023 | 33 d | 10-Q | $2.24B | +9.4% | -$1.03 | +5.2% | |
| Q2 2023 | Jun 30, 2023 | Aug 2, 2023 · after-hours | Aug 3, 2023 | 34 d | 10-Q | $2.17B | +10.2% | $0.07 | 0.6% | |
| Q1 2023 | Mar 31, 2023 | May 3, 2023 · after-hours | May 4, 2023 | 34 d | 10-Q | $1.94B | +1.4% | -$0.55 | 20.4% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Feb 22, 2023 · after-hours | Feb 23, 2023 | 54 d | 10-K | $2.19B | −0.1% | — | +11.2% | |
| Q3 2022 | Sep 30, 2022 | Nov 2, 2022 · after-hours | Nov 3, 2022 | 34 d | 10-Q | $2.05B | −3.1% | $1.10 | 1.2% | |
| Q2 2022 | Jun 30, 2022 | Aug 8, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $1.97B | −6.3% | -$0.40 | 11.3% | |
| Q1 2022 | Mar 31, 2022 | May 9, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | $1.92B | −5.4% | -$0.19 | 27.1% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Feb 22, 2022 · after-hours | Feb 23, 2022 | 54 d | 10-K | $2.20B | −0.8% | — | 4.3% | |
| Q3 2021 | Sep 30, 2021 | Nov 1, 2021 · after-hours | Nov 2, 2021 | 33 d | 10-Q | $2.11B | −1.3% | $0.52 | 9.3% | |
| Q2 2021 | Jun 30, 2021 | Aug 2, 2021 · after-hours | Aug 3, 2021 | 34 d | 10-Q | $2.10B | +26.2% | -$1.66 | 10.8% | |
| Q1 2021 | Mar 31, 2021 | May 3, 2021 · after-hours | May 4, 2021 | 34 d | 10-Q | $2.03B | +0.7% | -$1.71 | 10.8% | |
| FY 2020 | ||||||||||
| Q4 2020 | Dec 31, 2020 | Feb 23, 2021 · after-hours | Feb 24, 2021 | 55 d | 10-K | $2.21B | −0.5% | -$0.43 | 1.6% | |
| Q3 2020 | Sep 30, 2020 | Nov 2, 2020 · after-hours | Nov 3, 2020 | 34 d | 10-Q | $2.14B | −3.2% | $0.20 | 6.1% | |
| Q2 2020 | Jun 30, 2020 | Aug 5, 2020 · after-hours | Aug 6, 2020 | 37 d | 10-Q | $1.66B | −22.7% | -$0.92 | +6.0% | |
| Q1 2020 | Mar 31, 2020 | May 6, 2020 · after-hours | May 7, 2020 | 37 d | 10-Q | $2.01B | −0.2% | -$0.43 | 7.3% | |
| FY 2019 | ||||||||||
| Q4 2019 | Dec 31, 2019 | Feb 18, 2020 · after-hours | Feb 19, 2020 | 50 d | 10-K | $2.22B | +4.9% | -$4.30 | 5.8% | |
| Q3 2019 | Sep 30, 2019 | Nov 1, 2019 · after-hours | Nov 4, 2019 | 35 d | 10-Q | $2.21B | +3.4% | -$0.14 | +5.4% | |
| Q2 2019 | Jun 30, 2019 | Aug 5, 2019 · after-hours | Aug 6, 2019 | 37 d | 10-Q | $2.15B | +1.1% | -$0.49 | 4.0% | |
| Q1 2019 | Mar 31, 2019 | May 3, 2019 · after-hours | May 6, 2019 | 36 d | 10-Q | $2.02B | +1.1% | -$0.15 | +12.8% | |
| FY 2018 | ||||||||||
| Q4 2018 | Dec 31, 2018 | Feb 19, 2019 · after-hours | Feb 20, 2019 | 51 d | 10-K | $2.12B | −1.9% | -$0.98 | 4.5% | |
| Q3 2018 | Sep 30, 2018 | Nov 5, 2018 · after-hours | Nov 6, 2018 | 37 d | 10-Q | $2.14B | −3.7% | -$1.00 | +6.7% | |
| Q2 2018 | Jun 30, 2018 | Aug 6, 2018 · after-hours | Aug 7, 2018 | 38 d | 10-Q | $2.13B | −4.7% | -$2.49 | +5.4% | |
| Q1 2018 | Mar 31, 2018 | May 7, 2018 · after-hours | May 8, 2018 | 38 d | 10-Q | $2.00B | −5.4% | -$7.36 | — | |
| FY 2017 | ||||||||||
| Q4 2017 | Dec 31, 2017 | — | Feb 28, 2018 | 59 d | 10-K | $2.16B | −10.0% | $1.45 | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 7, 2017 | 38 d | 10-Q | $2.22B | −10.5% | $3.69 | — | |
| Q2 2017 | Jun 30, 2017 | — | Aug 8, 2017 | 39 d | 10-Q | $2.23B | −7.7% | -$0.11 | — | |
| Q1 2017 | Mar 31, 2017 | — | May 9, 2017 | 39 d | 10-Q | $2.11B | −11.1% | $1.79 | — | |
| FY 2016 | ||||||||||
| Q4 2016 | Dec 31, 2016 | — | Mar 1, 2017 | 60 d | 10-K | $2.40B | −12.9% | -$1.47 | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 9, 2016 | 40 d | 10-Q | $2.48B | −11.1% | -$3.49 | — | |
| Q2 2016 | Jun 30, 2016 | — | Aug 9, 2016 | 40 d | 10-Q | $2.42B | −11.5% | -$0.88 | — | |
| Q1 2016 | Mar 31, 2016 | — | Jun 7, 2016 | 68 d | 10-Q | $2.37B | +9.4% | -$1.08 | — | |
| FY 2015 | ||||||||||
| Q4 2015 | Dec 31, 2015 | — | Apr 29, 2016 | 120 d | 10-K | $2.76B | +23.4% | -$1.12 | — | |
| Q3 2015 | Sep 30, 2015 | — | Oct 26, 2015 | 26 d | 10-Q | $2.79B | +36.4% | $0.14 | — | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $2.73B | +33.9% | -$0.15 | — | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $2.17B | +15.0% | $0.28 | — | |
| FY 2014 | ||||||||||
| Q4 2014 | Dec 31, 2014 | — | — | — | — | $2.24B | +8.3% | $1.50 | — | |
| Q3 2014 | Sep 30, 2014 | — | Oct 24, 2014 | 24 d | 10-Q | $2.04B | +32.5% | $0.78 | — | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $2.04B | +86.3% | $0.37 | — | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $1.89B | +76.5% | -$0.07 | — | |
| FY 2013 | ||||||||||
| Q4 2013derived | Dec 31, 2013 | — | — | — | — | $2.06B | +124.3% | — | — | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $1.54B | +74.4% | -$2.92 | — | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $1.10B | +33.6% | $0.03 | — | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $1.07B | +24.8% | -$0.09 | — | |
| FY 2012 | ||||||||||
| Q4 2012derived | Dec 31, 2012 | — | — | — | — | $920.07M | +41.0% | — | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $884.14M | +47.2% | $0.02 | — | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $820.09M | +34.6% | -$0.07 | — | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $856.10M | +51.5% | -$0.04 | — | |
| FY 2011 | ||||||||||
| Q4 2011derived | Dec 31, 2011 | — | — | — | — | $652.45M | +26.8% | — | — | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $600.58M | +188.4% | $0.13 | — | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $609.39M | +155.2% | $0.17 | — | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $565.03M | +157.3% | $0.02 | — | |
| FY 2010 | ||||||||||
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | $514.56M | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $208.27M | −2.0% | -$1.27 | — | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $238.77M | +23.4% | $0.21 | — | |
| Q1 2010 | Mar 31, 2010 | — | — | — | — | $219.64M | — | -$0.02 | — | |
| FY 2009 | ||||||||||
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $212.52M | — | $0.25 | — | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $193.54M | — | $0.15 | — | |
Earlier years, FY 2009 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR